MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 49 filers reported holding MONTE ROSA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $259,666 | -16.4% | 54,210 | +19.6% | 0.00% | – |
| Q2 2023 | $310,552 | +23.7% | 45,336 | +40.7% | 0.00% | – |
| Q1 2023 | $251,095 | -24.9% | 32,233 | -26.7% | 0.00% | – |
| Q4 2022 | $334,551 | +23.0% | 43,962 | +32.0% | 0.00% | – |
| Q3 2022 | $272,000 | -29.9% | 33,294 | -17.0% | 0.00% | – |
| Q2 2022 | $388,000 | -44.4% | 40,116 | -19.5% | 0.00% | – |
| Q1 2022 | $698,000 | -1.7% | 49,817 | +43.4% | 0.00% | – |
| Q4 2021 | $710,000 | +66.7% | 34,746 | +81.7% | 0.00% | – |
| Q3 2021 | $426,000 | -82.7% | 19,119 | -82.4% | 0.00% | -100.0% |
| Q2 2021 | $2,463,000 | – | 108,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $12,029,000 | 7.99% |
| NEA Management Company, LLC | 7,703,205 | $62,935,000 | 3.14% |
| Cormorant Asset Management, LP | 2,993,717 | $24,459,000 | 1.71% |
| Alphabet Inc. | 1,464,015 | $11,961,000 | 0.61% |
| Avoro Capital Advisors LLC | 3,363,333 | $27,478,000 | 0.51% |
| Casdin Capital, LLC | 510,882 | $4,174,000 | 0.27% |
| RTW INVESTMENTS, LP | 1,214,572 | $9,923,000 | 0.23% |
| Woodline Partners LP | 502,411 | $4,105,000 | 0.06% |
| Virtus Investment Advisers, Inc. | 12,638 | $103,000 | 0.05% |
| CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $230,000 | 0.04% |